Recent Updates
Recently added Catalysts
CGTX Positive Sentiment

Sigma-2 Receptor Modulators Alter Low-density Lipoprotein Receptor-mediated Lipid Trafficking in Retinal Pigmented Epithelial Cells

Tuesday, September 24, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses a presentation by Lizama et al. on the effects of Sigma-2 receptor modulators on lipid trafficking in retinal pigmented epithelial cells. This research was showcased at the 2024 Keystone Conference focused on dry age-related macular degeneration. The findings may contribute to new therapeutic strategies for this condition.
Price reaction · baseline $0.5205 (2024-09-23 close) · hit pre-market · clean, no other CGTX news in the window
day 0 close
-6.2%
day 1 · peak
-20.3%
day 3
-19.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a notable conference highlights research significance.
  • Focus on Sigma-2 receptor modulators indicates innovative therapeutic approaches.
  • Research could lead to advancements in treating age-related macular degeneration.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
8.3%
average across 6 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Lead asset
Oxytocin
Phase 2 · Oxidative Stress

Full Press Release Details

Lizama BN, Reaver A, Cho E, et al. Sigma-2 Receptor Modulators Alter Low-density Lipoprotein Receptor-mediated Lipid Trafficking in Retinal Pigmented Epithelial Cells. Poster presented at 2024 Keystone Conference on Dry Age-related Macular Degeneration ; Pacific Grove, CA.

Frequently Asked Questions

What was presented at the 2024 Keystone Conference?

Research on Sigma-2 receptor modulators and their effects on lipid trafficking.

Who conducted the research on Sigma-2 receptor modulators?

The research was conducted by Lizama BN, Reaver A, Cho E, and colleagues.

What condition does the research focus on?

The research focuses on dry age-related macular degeneration.

Where was the Keystone Conference held?

The conference took place in Pacific Grove, CA.

ShareAdd on Google
Tags: CGTX Viatris Investor Conferences Healthcare Sigma-2 receptor lipid trafficking retinal cells age-related macular degeneration
Last updated: Sep 24, 2024

Biotech snapshot

Cash runway
$34M liquidity · $1M/mo burn
~33 mo
Minimal dilution risk
Lead asset
OxytocinPhase 2
Oxidative Stress →

Catalyst track record

+35%
best trade around CGTX's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CGTX.

See every catalyst's timing & PoA →